SECURITIES AND EXCHANGE COMMISSION
                              Washington D.C. 20549

                                   FORM 10-KSB

                  Annual Report Pursuant to Section 13 or 15(d)
                     of the Securities Exchange Act of 1934

                     For the fiscal year ended May 31, 2003
                         Commission File No. 333-61801

                       JURAK CORPORATION WORLD WIDE, INC.
             (Exact name of registrant as specified in its charter)

            Minnesota                                      88-0407679
  (State or other jurisdiction                 (IRS Employer Identification No.)
of Incorporation or Organization)

                            1181 Grier Drive, Suite C
                             Las Vegas, Nevada 89119
               (Address of principal executive office) (Zip Code)

                  Registrant's telephone number: (702) 914-9688

           Securities registered pursuant to Section 12(b) of the Act:
                        3,000,000 Shares Of Common Stock

           Securities registered pursuant to Section 12(g) of the Act:
                                      None

                          Common Stock, (no par value)
                                (Title of Class)

Indicate by check mark whether the Registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the Registrant was
required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days. Yes_X_ NO___

The aggregate market value of the voting stock held by non-affiliates of the
Registrant on May 31, 2003, based on the average bid and asked prices of Common
Stock in the over-the-counter market on that date was $7,211,625.

15,527,750 shares of Registrant's Common Stock, no par value were outstanding on

<PAGE>

May 31, 2003, prior to the effectiveness of the latest practicable date.

                                    CONTENTS
                                    --------

                                                                            Page
                                                                            ----

PART I
         Item 1.  BUSINESS                                                    4

         Item 2.  PROPERTY                                                    6

         Item 3.  LEGAL PROCEEDINGS                                           7

         Item 4.  SUBMISSION OF MATTERS TO A VOTE
                  OF SECURITY HOLDERS                                         7


PART II
         Item 5.  MARKET FOR REGISTRANT'S COMMON
                  EQUITY AND RELATED STOCKHOLDER
                  MATTERS                                                     7

         Item 6.  SELECTED FINANCIAL DATA                                     8

         Item 7.  MANAGEMENT'S DISCUSSION AND
                  ANALYSIS OF FINANCIAL CONDITION
                  AND RESULTS OF OPERATIONS                                   8

         Item 8.  FINANCIAL STATEMENTS AND
                  SUPPLEMENTARY DATA                                          9

         Item 9.  DISAGREEMENTS ON ACCOUNTING AND
                  FINANCIAL DISCLOSURE                                        9


PART III
         Item 10. DIRECTORS AND EXECUTIVE OFFICERS
                  OF THE REGISTRANT                                           9

         Item 11. EXECUTIVE COMPENSATION                                     10

         Item 12. SECURITY OWNERSHIP OF CERTAIN
                  BENEFICIAL OWNERS AND MANAGEMENT                           10


                                       2
<PAGE>

         Item 13. CERTAIN RELATIONSHIPS AND RELATED
                  TRANSACTIONS                                               11


PART IV

         Item 14. EXHIBITS, FINANCIAL STATEMENT
                  SCHEDULES AND REPORTS ON FORM 8-K                          11



                                   PART I


Item 1. - BUSINESS
------

         The Jurak Classic Whole Body Tonic was first developed in 1945 by Carl
Jurak, the father of the founder of the Company. The tonic is a blend of
medicinal herbs, and other ingredients. The corporation was formed in Minnesota
on November 1, 1997.

         There are 30 separate ingredients to the tonic, all of them readily
available from suppliers in Canada, the United States and France. The Jurak
Classic Whole Body Tonic is supplied in bottles of one fluid oz. The bottles
come in boxes of 35 bottles.

         The tonic is a herbal supplement. The ingredients of the tonic include
chamomile, dandelion, licorice, passion flower, peppermint, saw palmetto, and
celery seed

         The Company has made arrangements with a supplier, Confab Laboratories,
Inc., to blend the raw materials and package them in the mono dose package. This
supplier has the capacity to manufacture 180 million mono dose packages a year.
There are a number of other suppliers, but the plan of the Company is to
establish a long term relationship with the supplier to establish cost stability
and first class service.

         The regulatory authority over dietary supplements is divided between
the Food and Drug Administration (FDA) and the Federal Trade Commission (FTC).
The FDA has authority to review the ingredients and safety, define misbranding,
and punish adulteration. The FTC regulates claims made in advertising and
promotional materials. The Company is a multi level distributor and does not
advertise nor issue promotional materials, so its activities are not regulated
by the FTC, only by the FDA.

         The Congress of the United States established standards governing
dietary supplements when it enacted the Dietary Supplement Health and Education
Act (DSHEA) in 1994. The focus of DSHEA has been to limit the authority of the
FDA over dietary supplements. Now the DSHEA regulations, effective March 23,
1999, require certain additional labeling, all of which the tonic product
contains. The display panel for the Company states: "Jurak Classic Whole Body
Tonic Dietary Supplement," "Corrective and Digestive Herbal and Mineral
Supplement." It adds "This statement has not been evaluated by the Food and Drug
Administration. This product is not intended to cure, mitigate, treat or prevent
any disease." The labeling also includes nutritional labeling,


                                       3
<PAGE>

including the Latin name and plant part.

         The Company filed a DSHEA required notice with the FDA that it was
going to market the product, and the FDA has not objected. Management of the
Company feels that it is in full compliance with the regulations of the FDA and
the FTC.

         The Company has worked with consultants to make sure that the labeling
of the product is correct and that the labeling is attractive. The cost of
compliance is the cost of the consultants. The Company has had the ingredients
approved in the United States, and the manufacturer is certified as a
manufacturer in Canada.

         Management of the Company has resolved to market the products through
network marketing in the United States and throughout the rest of the world.
Network marketing consists of distributors several layers deep that distribute
product for a specific company. Profits come from commissions on direct sales
and money earned on sales made by the network of downline distributors. Sales
are made by the distributors to individuals, there are no sales to retailers.

         The Company competes in the dietary supplement business, but there are
few companies selling products similar to the product of the Company. One
slightly similar product is Matol, for which Mr. Jurak worked for several years.
Mr. Jurak has no present connection with Matol except as a shareholder. He is
the holder of 2,000,000 preferred shares, which is one half of the preferred
shares. His preferred shares issued, however, have no voting rights. Matol is
based upon, but is a variation of, one of the many formulas of Carl Jurak.
Matol's product is sold in the United States as KM, which is sold as a Potassium
Mineral Supplement. There is at least one other product that is very similar to
Matol, BOTANOL, which is sold as an improvement to KM. The formula used for the
Jurak Classic Whole Body Tonic is different from those two in that it contains a
greater quantity of herbs and minerals, and the herbs in them are not all tonic
herbs, as is the case with the product of the Company, are not bi-directional
and would not act to balance the systems in the body. The Company feels that any
litigation from either of the other two products is remote. The Company has no
patents and has applied for trademarks for its products and logos.

         The Jurak Classic Whole Body Tonic is the only product of the Company
at this time. However Carl Jurak developed several formulas, and some of them
were manufactured and sold many years ago. There is a variety of organ specific
herbal tablets and liquids as well as salves, ointments and liniments. The cost
to develop them is minimal because the cost will be to prepare pilot batches,
test them, and determine whether the product's ingredients and proposed labeling
comply with FDA requirements.


                                       4
<PAGE>


         The Company is marketing the Jurak Classic Whole Body Tonic through
network marketing, called the Jurak Career Plan. There are a number of steps in
the Jurak Career Plan, starting with the Independent Distributor. An Independent
Distributor registers with the Company and gets the right to sponsor other
persons to purchase the product at a 30% discount from the retail price. There
are points awarded for personal consumption or sale of products. One may become
a Qualified Distributor when he has 160 points monthly.

         In addition to the money made by the distributor on sales the Company
intends to issue shares of its stock to its distributors as an added incentive,
with the agreement that the shares of stock are restricted from sale for three
years from the time of being earned. A distributor who purchases enough product
for 160 points, sponsors three persons who each purchase enough product for 160
points and who in turn sponsor three additional persons who each purchase enough
product for 160 points will receive 10 certificates valued at $5.00 each. The
aggregate value for certificates earned will be redeemable for shares at the
current market price at the time the shares were earned.

         Network marketing is known for persons switching to another company
with a better idea. The strategy of including the Company's distributors as
shareholders is to keep the distributors close to the Company for a long time,
and build into the future.

         Also with a consultant the Company has developed custom designed
software to interface with the sales and bonus system. The software also process
currencies of other countries so that when there is expansion into other
countries the system will be able to handle the volume.

         Through Eagle Payment Solutions the Company has obtained merchant
credit card processing capabilities with Moneris Solutions.

         The Company has a license royalty agreement, with an entity controlled
by Mr. Jurak. The agreement provides that 8% of net sales, as defined in the
agreement, are paid to the entity, to be used for charitable purposes. The
amount expensed for the years ended May 31, 2003 and 2002 was $143,400 and
$84,000 respectively, and these are included in amounts payable to related
party.

         The Company has nine full time employees, and one part time employee,
none are represented by a labor organization. The 10 employees do not include
independent distributors.


                                       5
<PAGE>

Item 2. - PROPERTY
------

Facilities
----------

         The Company has leased 8,500 square feet of office space in Las Vegas,
Nevada for its offices and warehouse, at a monthly rental of $6,008, plus
operating expenses. The warehouse will be used to hold and distribute the
Company's products. A part of the warehouse may be used for a research and
development laboratory.


Item 3. - LEGAL PROCEEDINGS
-------

         None


Item 4. - SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
-------

         There was an annual meeting of shareholders held on July 18, 2003. At
the meeting Anthony Jurak and Roger Theriault were elected to the Board of
Directors and Virchow, Krause & Company, LLP were retained as independent
auditors.


                                     PART II

Item 5. - MARKET FOR REGISTRANT'S COMMON EQUITY AND RELATED
-------

             STOCKHOLDER MATTERS

         The Company's common stock has been traded since February 16, 2000 on
the OTC Bulletin Board, before that time there was no activity. As of May 31,
2003 the following brokerage firms were making a market in the Company's common
stock: Jill Thompson Magid & Co., Sharpe Capital, Inc., and Knight Securities,
Inc.

         The following table sets forth for the periods indicated the range of
high and low closing bid quotations per share as reported by the
over-the-counter market. These quotations represent inter-dealer prices, without
retail markups, markdowns or commissions and may not represent actual
transactions.

                                                               Price per Share
                                                               ---------------
                                                             High           Low
                                                             ----           ---
Fiscal year 2002
         First quarter (June 1, 2001                        $5.00          $4.00
         through August 31, 2001)


                                       6
<PAGE>


         Second quarter (September 1, 2001                  $5.00          $4.00
         through November 30, 2001)

         Third quarter (December 1, 2001                    $ .12          $ .12
         through February 28, 2002)

         Fourth quarter (March 1, 2002                      $ .12          $ .12
         through May 31, 2002)


Fiscal year 2003
         First quarter (June 1, 2002                        $ .62          $ .62
         through August 31, 2002)

         Second quarter (September 1, 2002                  $ .62          $ .62
         through November 30, 2002)

         Third quarter (December 1, 2002                    $ .62          $ .62
         through February 28, 2003)

         Fourth quarter (March 1, 2003                      $1.50          $1.50
         through May 31, 2003)

         There have never been any dividends, cash or otherwise, paid on the
common shares of the Company.


Item 6. - SELECTED FINANCIAL DATA
-------

                                                    Fiscal Years Ended May 31,
                                                    --------------------------
                                                       2003             2002
                                                       ----             ----
Income Statement Data
---------------------
   Net Sales                                       $ 2,583,355      $ 1,559,126
   Net Income (loss)                               $  (558,916)     $  (370,994)
Per Share Data
--------------
Net Income (loss)                                  $      (.04)     $      (.02)


                                                            As of May 31,
                                                            -------------
                                                        2003             2002
                                                        ----             ----
Balance Sheet Data
------------------
   Total Assets                                     $   345,880     $   217,810
   Total Liabilities                                $ 2,504,702     $ 1,817,716
   Stockholders' Equity (Deficit)                   $(2,158,822)    $(1,599,906)


                                       7
<PAGE>


Item 7. - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL
-------   CONDITION AND RESULTS OF OPERATIONS


RESULTS OF OPERATIONS

         The Company had revenue from sales of its products at May 31, 2002 of
$1,559,126, and in the year ended May 31, 2003 sales were $2,583,355,
approximately a 60% gain over the prior year. During the same period the Company
expended general, administrative and operating expenses of $1,819,950 in 2002,
compared to expenses of $2,779,733 in 2003, approximately an increase of 65%.
There was a net loss of $370,994 in 2002, compared to a net loss of $588,916 in
2003. The general, administrative and pre-operating expenses included consulting
expenses for Food and Drug Administration advice, computer consultants, hardware
and software, raw materials, travel, office, telephone expenses, legal fees,
rent and wages.


LIQUIDITY AND CAPITAL RESOURCES

         The Company has financed its operations with equity capital, and raised
a total of $584,686. In addition a stockholder has advanced $1,440,066 to the
Company. The business the Company is engaged in is not capital intensive, and
the Company hopes to be able to finance its future operations from the cash flow
from sales of the products of the Company. The business of the Company is not
capital intensive because it does not need to purchase any machinery, the costs
of the raw material is negligible, and, because all sales will be by check or
credit card, there are no significant accounts receivable.

         The Company has no plans to raise additional capital through private
placements or otherwise in the next 12 months. The only need for capital would
be if the Company deemed it a good investment to do its own manufacturing.


PRODUCT RESEARCH AND DEVELOPMENT

         The Company does not anticipate conducting any product research and
development during the next 12 months that would require significant capital.


PURCHASES OR SALE OF PLANT AND EQUIPMENT

         The Company anticipates that it will not need any purchases of plant or
equipment in the near future.


                                       8
<PAGE>


RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS

         In June 2002, Financial Accounting Standards Board (FASB) issued
Statement of Financial Accounting Standards (SFAS) No. 146, "Accounting for
Costs Associated with Exit or Disposal Activities." SFAS No. 146 requires the
recognition of a liability for a cost associated with an exit or disposal
activity when the liability is incurred versus the date the Company commits to
an exit plan. In addition, SFAS No. 146 states the liability should be initially
measured at fair value. The requirements of SFAS No. 146 are effective for exit
or disposal activities that are initiated after December 31, 2002. Adoption of
SFAS No. 146 did not have a material effect on the Company's financial
statements.




















                                       9
<PAGE>


         In October 2002, FASB issued SFAS No. 147, "Acquisitions of Certain
Financial Institutions." SFAS No. 147 is effective October 1, 2002. The Company
believes the adoption of SFAS No. 147 will not have a material effect on the
Company's financial statements.

         In December 2002, the FASB issued SFAS No. 148, "Accounting for
Stock-Based Compensation - Transition and Disclosure." SFAS No. 148 is an
amendment to SFAS No. 123 providing alternative methods of transition for a
voluntary change to the fair value based method of accounting for stock-based
employee compensation and also provides additional disclosures about the method
of accounting for stock-based employee compensation. Amendments are effective
for financial statements for fiscal years ending after December 15, 2002 and for
the interim periods beginning after December 15, 2002. The Company does not have
a stock option plan or stock options outstanding and, as such, SFAS No. 123 and
148 does not impact the Company's financial statements.

         In April 2003, the FASB issued SFAS No. 149, "Amendment of Statement
133 on Derivative Instruments and Hedging Activities," effective for contracts
entered into or modified after June 30, 2003. This amendment clarifies when a
contract meets the characteristics of a derivative, clarifies when a derivate
contains a financing component and amends certain other existing pronouncements.
The Company believes the adoption of SFAS No. 149 will not have a material
effect on the Company's financial statements.

         In May 2003, the FASB issued SFAS No. 150, "Accounting for Certain
Financial Instruments with Characteristics of both Liabilities and Equity." SFAS
No. 150 is effective for financial instruments entered into or modified after
May 31, 2003, and otherwise is effective at the beginning of the first interim
period beginning after June 15, 2003. SFAS No. 150 requires the classification
as a liability of any financial instruments with a mandatory redemption feature,
an obligation to repurchase equity shares, or a conditional obligation based on
the issuance of a variable number of its equity shares. The Company believes the
adoption of SFAS No. 150 will not have a material effect on the Company's
financial statements.

In November 2002, the FASB issued FASB Interpretation No. 45, "Guarantor's
Accounting and Disclosure Requirements for Guarantees, Including Indirect
Guarantees of Indebtedness of Others" (FIN 45). FIN 45 clarifies the
requirements for a guarantor's accounting for and disclosure of certain
guarantees issued and outstanding. The initial recognition and initial
measurement provisions of FIN 45 are applicable to guarantees issued or modified
after December 31, 2002. The disclosure requirements of FIN 45 are effective for
financial statements for periods ending after December 15, 2002. The adoption of
FIN 45 did not impact the Company's financial statements.

In January 2003, the FASB issued FASB Interpretation No. 46, "Consolidation of
Variable Interest Entities" (FIN 46). FIN 46 states that companies that have
exposure to the economic risks and potential rewards from another entity's
assets and activities have a controlling financial interest in a variable
interest entity and should consolidate the entity, despite the absence of clear
control through a voting equity interest. The consolidation requirements apply
to all variable interest entities created after January 31, 2003. For variable
interest entities that existed prior to February 1, 2003, the consolidation
requirements are effective for annual or interim periods beginning after June
15, 2003. Disclosure of significant variable interest entities is required in
all financial statements issued after January 31, 2003, regardless of when the
variable interest was created. The Company does not expect the adoption of FIN
46 to have a material impact on the Company's financial statements.


SIGNIFICANT ACCOUNTING POLICIES

         Financial Reporting Release No. 60, which was recently released by the
Securities and Exchange commission, requires all companies to include a
discussion of critical accounting policies or methods used in the preparation of
financial statements. Note 1 of the Notes to the Financial Statements includes a
summary of the significant accounting policies and methods used in the
preparation of our Financial Statements. The following is a brief discussion of
the more significant accounting policies and methods used by the company. In
addition, Financial Reporting Release No. 61 was


                                       10
<PAGE>


recently released by the SEC to require all companies to include a discussion to
address, among other things, liquidity, off-balance sheet arrangements,
contractual obligations and commercial commitments.

         General

         The preparation of financial statements in conformity with accounting
principles generally accepted in the United States of America requires
management to make estimates and assumptions that affect the reported amounts of
assets and liabilities and the disclosure of contingent assets and liabilities
at the dates of the financial statements and reported amounts of revenues and
expenses during the reporting periods. The most significant estimates and
assumptions relate to the valuation of inventory and the liability for the stock
bonus plan. Actual amounts could differ from these estimates.

         Inventory Valuation

         As noted in Note 1 of the Notes to the Financial Statements,
inventories consist primarily of raw materials, finished goods and supplies and
are valued at the lower of cost or market (first-in, first-out method).

         Stock Bonus Plan

         As noted in Note 5 of the Notes to the Financial Statements,
distributors are awarded points based on sales which will be redeemable for
shares of the Company. The amount of the liability for this plan at May 31, 2003
is approximately $217,321.


Item 8. - FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
-------

         The financial statements are attached following Item 14.


Item 9. - DISAGREEMENTS ON ACCOUNTING AND FINANCIAL DISCLOSURE.
-------

         None.


                                    PART III

Item 10. - DIRECTORS AND EXECUTIVE OFFICERS OF THE REGISTRANT.
--------


                                       11
<PAGE>


         The executive officers and directors of the Company, with a brief
description, are as follows:

Name                    Age              Position
----                    ---              --------

Anthony Carl Jurak      65               Chairman, Secretary

Roger Theriault         57               President, Director

Maria Jose Guedes       34               Vice President of Operations, Assistant
                                         Secretary-Treasurer

         Anthony Carl Jurak, Mr. Jurak is the Chairman, Secretary, and a
Director of the Company. Mr. Jurak has been Co-Chairman and Secretary Treasurer
for more than the past 5 years of Matol Partners Corporation until February,
1997, and since has worked as a founder of the Company. While with Matol he was
in charge of finances for six years, and then committed his time to marketing
the products by traveling to sales and marketing meetings.

         Roger Theriault, Mr. Theriault is the President and a Director of the
Company. Mr. Theriault was the Director of National Sales for Shaklee Canada
from 1979 to 1984. During that time he was mostly involved in marketing of the
Company's products, he was responsible for three regional sales managers and
more than 100,000 distributors. He was the founder of Nova Sante Pacific
International where he worked form 1989 to 1994. Since 1995 he has been a
consultant to Triple Gold (Ecuador), Radical Advance Technologies and CiDem
(France).

         Maria Jose Guedes, Ms Guedes is Vice President of Operations and
Assistant Secretary-Treasurer. Ms Guedes is a graduate of Notre Dame College
(Canada) with a degree in business. She has been employed by the Company since
1997.

         The directors of the Company are elected annually by the shareholders
for a term of one year or until their successors are elected and qualified. The
officers serve at the pleasure of the Board of Directors.


Item 11. - EXECUTIVE COMPENSATION.
--------

         There are no officers or directors that received compensation in excess
of $100,000 or more during the last year. Management has taken no remuneration
to date, except as noted in Certain Transactions. There is a liability to Mrs.
Guedes and her husband of $63,665 at May 31, 2003 and $4,075 at May 31, 2002 for
compensation that bears no interest.


                                       12
<PAGE>


Item 12. - SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS
--------   AND MANAGEMENT.

         There are presently 15,527,750 shares of the Company's common shares
outstanding. The following table sets forth the information as to the ownership
of each person who, as of this date, owns of record, or is known by the Company
to own beneficially, more than five per cent of the Company's common stock, and
the officers and directors of the Company.

                            Shares of                     Percentage of
Name                        Common Stock                  Ownership
--------------------------------------------------------------

Anthony Carl Jurak(1)          9,220,000                   60%

Roger Theriault                1,500,000                   10%

Michael Fielding               1,500,000                   10%

Roger Matthews                 1,300,000                    8%

John H. Picken                   920,000                    6%

All officers and directors    10,720,000                   70%
as a group

(1) Mr. Jurak's shares are in the name of Jurak Holdings, Ltd.


Item 13. - CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS.
--------

         Beginning in September, 1997, before the Company was incorporated, the
founder of the Company, Anthony Carl Jurak, began paying expenses for the start
of the Company. The expenses paid were done by the personal credit cards of Mr.
Jurak. He has advanced to the Company or requested reimbursement for $1,440,066
and $1,314,920 as of May 31, 2003 and 2002 respectively. Interest on the
advances is at 8% and a total of $103,097 and $95,300 was charged to operations
for the years ended May 31, 2003 and 2002 respectively.


                                       13
<PAGE>


         The Company reimbursed Jurak Holdings, Ltd., a Canadian company
controlled by Mr. Jurak, $51,687 for legal fees for trade name protection in
Canada.

         The Company expensed $182,431 to Jurak Holdings, Ltd. in 2003 for
consulting fees, in lieu of compensation to Mr. Jurak, Mr. Theriault, and a
computer consultant. Mr. Jurak was paid $61,028, Mr. Theriault was paid $52,388
and the computer consultant was paid $50,856. There is no written contract or
obligation for these payments. There is a liability of $141,859 at May 31, 2003,
and $111,877 at May 31, 2002 for Mr. Theriault, at no interest.


                                     PART IV


Item 14. - EXHIBITS, FINANCIAL STATEMENT SCHEDULES AND
--------   REPORTS ON FORM 8-K.

CONTROLS AND PROCEDURES

         It is the responsibility of the chief executive officer and chief
financial officer to ensure the company maintains disclosure controls and
procedures designed to provide reasonable assurance that material information,
both financial and non-financial, and other information required under the
securities laws to be disclosed is identified and communicated to senior
management on a timely basis. The company's disclosure controls and procedures
include mandatory communication of material subsidiary events, automated
accounting processing and reporting, management review of monthly and quarterly
results, periodic subsidiary business reviews, an established system of internal
controls and rotating internal control reviews by the company's internal
auditors.

         The chief executive officer and chief financial officer evaluated the
company's disclosure controls and procedures as of the end of the fiscal year,
and have concluded the controls and procedures currently in place are adequate
to ensure material information and other information requiring disclosure is
identified and communicated on a timely basis.

         Additionally, there have been no material changes to the company's
system of internal controls or changes in other factors affecting the operation
of the internal controls in the year since Jurak Corporation World Wide
management last evaluated the system of internal controls in conjunction with
the preparation of financial statements for the year ended May 31, 2002.


                                       14
<PAGE>


         The Company paid its auditor, Virchow, Krause & Company, LLP, audit and
related fees of $20,100, tax and related fees of $10,005 for a total of $30,105
in the past year.

         (a) Attached are the Financial Statements and Independent Auditor's
             Report on Examination of Financial Statements for the years ended
             May 31, 2003 and May 31, 2002.

         (b) Attached are the following Financial Statement Schedules and
             Auditors Report on Schedules.

             None

             All schedules are omitted because they are not required or not
             applicable or the information is shown in the financial statements
             or notes thereto.

         (c) No report was filed on Form 8-K.

         (d) Exhibit 31 - Certification of Anthony Jurak pursuant to Section 302
             of the Sarbanes-Oxley Act of 2002 (Rules 13a-14 and 15d-14 of the
             Exchange Act).

             Exhibit 32 - Certification of Anthony Jurak pursuant Section 906 of
             the Sarbanes-Oxley Act of 2002 (18 U.S.C. ss. 1350).





                                   SIGNATURES


         Pursuant to the requirements of Section 13 or 15(d) of the Securities
Exchange Act of 1934 the registrant has duly caused this report to be signed on
its behalf by the undersigned, who is duly authorized.

Dated: September 12, 2003
                                              /s/ Anthony Jurak
                                              ----------------------------------
                                              JURAK CORPORATION WORLD WIDE, INC.




                                       15
<PAGE>















                                JURAK CORPORATION
                                WORLD WIDE, INC.


                                FINANCIAL REPORT

                              MAY 31, 2003 AND 2002

<PAGE>





                          INDEPENDENT AUDITORS' REPORT



To the Board of Directors and Stockholders
Jurak Corporation World Wide, Inc.


         We have audited the accompanying balance sheets of Jurak Corporation
World Wide, Inc., a Minnesota corporation, as of May 31, 2003 and 2002, and the
related statements of operations, stockholders' deficit and cash flows for the
years then ended. These financial statements are the responsibility of the
Company's management. Our responsibility is to express an opinion on these
financial statements based on our audits.

         We conducted our audits in accordance with auditing standards generally
accepted in the United States of America. Those standards require that we plan
and perform the audit to obtain reasonable assurance about whether the financial
statements are free of material misstatement. An audit includes examining, on a
test basis, evidence supporting the amounts and disclosures in the financial
statements. An audit also includes assessing the accounting principles used and
significant estimates made by management, as well as evaluating the overall
financial statement presentation. We believe that our audits provide a
reasonable basis for our opinion.

         In our opinion, the financial statements present fairly, in all
material respects, the financial position of Jurak Corporation World Wide, Inc.
as of May 31, 2003 and 2002, and the results of its operations and its cash
flows for the years then ended, in conformity with accounting principles
generally accepted in the United States of America.

         The accompanying financial statements have been prepared assuming that
the Company will continue as a going concern. As discussed in Note 6 to the
financial statements, the Company has suffered recurring losses from operations
and its total liabilities exceed its total assets. These factors raise
substantial doubt about its ability to continue as a going concern. Management's
plans in regard to these matters are also described in Note 6. The financial
statements do not include any adjustments that might result from the outcome of
this uncertainty.




                                   VIRCHOW, KRAUSE & COMPANY, LLP

Minneapolis, Minnesota
July 25, 2003

<PAGE>

                       JURAK CORPORATION WORLD WIDE, INC.

                                 BALANCE SHEETS
                              May 31, 2003 and 2002

<TABLE>
<CAPTION>
        ASSETS                                                          2003            2002
                                                                    -----------     -----------
<S>                                                                 <C>             <C>
CURRENT ASSETS:
    Cash and cash equivalents                                       $    13,749     $        --
    Inventories                                                         251,779          99,628
                                                                    -----------     -----------
        Total current assets                                            265,528          99,628

RESTRICTED CASH                                                          35,644          70,644

DEPOSITS                                                                 28,900          28,900

OFFICE FURNISHINGS AND EQUIPMENT, less
    accumulated depreciation 2003 $100,941; 2002 $93,441                 15,808          18,638
                                                                    -----------     -----------

                                                                    $   345,880     $   217,810
                                                                    ===========     ===========

        LIABILITIES AND STOCKHOLDERS' DEFICIT

CURRENT LIABILITIES:
    Checks issued in excess of bank balance                         $        --     $    10,423
    Accounts payable                                                    331,662          57,474
    Accrued compensation                                                497,238         286,563
    Accrued royalties                                                   235,736         148,336
    Payable to stockholder, officer                                   1,440,066       1,314,920
                                                                    -----------     -----------
        Total current liabilities                                     2,504,702       1,817,716


STOCKHOLDERS' DEFICIT:
    Convertible preferred stock, par value $.001 per share,
        50,000,000 shares authorized, none issued or outstanding             --              --
    Common stock, par value $.001 per share, 150,000,000 shares
        authorized, 15,527,750 shares issued and outstanding             15,528          15,528
    Additional paid-in capital                                          569,158         569,158
    Accumulated deficit                                              (2,743,508)     (2,184,592)
                                                                    -----------     -----------
        Total stockholders' deficit                                  (2,158,822)     (1,599,906)
                                                                    -----------     -----------

                                                                    $   345,880     $   217,810
                                                                    ===========     ===========
</TABLE>


See Notes to Financial Statements.


                                       2
<PAGE>

                       JURAK CORPORATION WORLD WIDE, INC.

                            STATEMENTS OF OPERATIONS
                        Years Ended May 31, 2003 and 2002



                                                    2003             2002
                                                ------------     ------------

Sales                                           $  2,583,355     $  1,559,126
Cost of sales                                        367,949          105,734
                                                ------------     ------------
             Gross profit                          2,215,406        1,453,392

Selling, general and administrative expenses      (2,779,733)      (1,819,950)
Other income (expense)                                 5,411           (4,436)
                                                ------------     ------------

             Net loss                           $   (558,916)    $   (370,994)
                                                ============     ============


Basic loss per common share                     $       (.04)    $       (.02)
                                                ============     ============

Diluted loss per common share                   $       (.04)    $       (.02)
                                                ============     ============

Weighted average outstanding common shares        15,527,750       15,527,750
                                                ============     ============


See Notes to Financial Statements.












                                       3
<PAGE>

                       JURAK CORPORATION WORLD WIDE, INC.

                       STATEMENTS OF STOCKHOLDERS' DEFICIT
                        Years Ended May 31, 2003 and 2002


                              Common Stock            Additional
                       --------------------------      Paid-In       Accumulated
                          Shares         Amount        Capital         Deficit
                       -----------    -----------    -----------    -----------

Balance, May 31, 2001   15,527,750    $    15,528    $   569,158    $(1,813,598)
    Net loss                    --             --             --       (370,994)
                       -----------    -----------    -----------    -----------

Balance, May 31, 2002   15,527,750         15,528        569,158    $(2,184,592)
    Net loss                    --             --             --       (558,916)
                       -----------    -----------    -----------    -----------

Balance, May 31, 2003   15,527,750    $    15,528    $   569,158    $(2,743,508)
                       ===========    ===========    ===========    ===========




See Notes to Financial Statements.










                                       4
<PAGE>


                       JURAK CORPORATION WORLD WIDE, INC.

                            STATEMENTS OF CASH FLOWS
                        Years Ended May 31, 2003 and 2002

<TABLE>
<CAPTION>
                                                                       2003          2002
                                                                    ---------     ---------
<S>                                                                 <C>           <C>
CASH FLOWS FROM OPERATING ACTIVITIES:
    Net loss                                                        $(558,916)    $(370,994)
    Depreciation                                                        7,500        29,000
    Increase in accounts receivable                                        --           188
    Increase in inventories                                          (152,151)       (7,767)
    Increase in accounts payable                                      274,188        33,796
    Increase in accrued compensation and accrued royalties            298,075       182,190
                                                                    ---------     ---------
             Net cash used in operating activities                   (131,304)     (133,587)
                                                                    ---------     ---------

CASH FLOWS FROM INVESTING ACTIVITIES:
    Purchase of office equipment                                       (4,670)       (2,100)
    Decrease in restricted cash                                        35,000            --
                                                                    ---------     ---------
             Net cash provided by (used in) investing activities       30,330        (2,100)
                                                                    ---------     ---------

CASH FLOWS FROM FINANCING ACTIVITIES:
    Checks issued in excess of bank balance                           (10,423)       10,423
    Increase in payable to stockholder, officer                       125,146        91,918
                                                                    ---------     ---------
             Net cash provided by financing activities                114,723       102,341
                                                                    ---------     ---------

Increase (decrease) in cash and cash equivalents                       13,749       (33,346)

Cash and cash equivalents:
    Beginning                                                              --        33,346
                                                                    ---------     ---------

    Ending                                                          $  13,749     $      --
                                                                    =========     =========

SUPPLEMENTAL CASH FLOW DISCLOSURES
    Cash paid for interest                                          $   1,250     $  13,376
                                                                    =========     =========
</TABLE>


See Notes to Financial Statements.



                                       5
<PAGE>


                       JURAK CORPORATION WORLD WIDE, INC.

                          NOTES TO FINANCIAL STATEMENTS
                              May 31, 2003 and 2002


Note 1.   Nature of Business and Summary of Significant Accounting Policies:

          NATURE OF BUSINESS:

          Jurak Corporation World Wide, Inc. (the Company) was incorporated on
          November 3, 1997 in the State of Minnesota, is located in Las Vegas,
          Nevada, and markets its products throughout the U.S. and Canada. The
          Company manufactures and markets dietary and herbal supplement
          products.

          A summary of the Company's significant accounting policies follows:

          CASH AND CASH EQUIVALENTS:

          The Company considers all highly liquid debt instruments purchased
          with a maturity of three months or less to be cash equivalents.

          INCOME TAXES:

          Deferred taxes are provided on a liability method whereby deferred tax
          assets are recognized for deductible temporary differences and
          operating loss and tax credit carryforwards and deferred tax
          liabilities are recognized for taxable temporary differences.
          Temporary differences are the differences between the reported amounts
          of assets and liabilities and their tax basis. Deferred tax assets are
          reduced by a valuation allowance when, in the opinion of management,
          it is more likely than not that some portion or all of the deferred
          tax assets will not be realized. Deferred tax assets and liabilities
          are adjusted for the effects of changes in tax laws and rates on the
          date of the enactment.

          INVENTORIES:

          Inventories are valued at the lower of cost (first-in, first-out
          method) or market and consist of the following:

                                                           May 31
                                               -----------------------------
                                                   2003              2002
                                               -----------       -----------
               Raw materials                   $    14,422       $    16,287
               Finished goods and supplies         237,357            83,341
                                               -----------       -----------
                                               $   251,779       $    99,628
                                               ===========       ===========

          OFFICE FURNISHINGS AND EQUIPMENT:

          Office furnishings and equipment are recorded at cost and depreciated
          on a straight-line basis over their estimated useful life of three to
          seven years. Maintenance repairs and minor renewals are expensed when
          incurred.

          ADVERTISING:

          The Company expenses advertising costs as they are incurred.
          Advertising costs were $9,879 and $32,681 for the years ended May 31,
          2003 and 2002, respectively.


                                       6
<PAGE>

Note 1.   Nature of Business and Summary of Significant Accounting Policies
          (Continued):


          SHIPPING AND HANDLING COSTS:

          Shipping and handling costs charged to customers have been included in
          sales. Inbound freight and handling costs incurred by the Company have
          been included in cost of sales. Outgoing shipping costs of $155,787
          and $109,923 were included in selling, general and administrative
          expenses for the years ended May 31, 2003 and 2002, respectively.

          REVENUE RECOGNITION:

          The Company recognizes sales when the product is shipped. The Company
          ensures that the transaction complies with the seven conditions and
          the six considerations contained in Accounting and Auditing
          Enforcement Release No. 108 of the Securities and Exchange Commission.

          CARRYING VALUE OF FINANCIAL INSTRUMENTS:

          The carrying value of the Company's financial instruments approximates
          fair value at May 31, 2003 and 2002. The carrying amounts for cash,
          accounts payable and other accrued liabilities approximate fair value
          because of the short maturity of these instruments.

          RECENTLY ISSUED ACCOUNTING PRONOUNCEMENT:

          In June 2002, Financial Accounting Standards Board (FASB) issued
          Statement of Financial Accounting Standards (SFAS) No. 146,
          "Accounting for Costs Associated with Exit or Disposal Activities."
          SFAS No. 146 requires the recognition of a liability for a cost
          associated with an exit or disposal activity when the liability is
          incurred versus the date the Company commits to an exit plan. In
          addition, SFAS No. 146 states the liability should be initially
          measured at fair value. The requirements of SFAS No. 146 are effective
          for exit or disposal activities that are initiated after December 31,
          2002. Adoption of SFAS No. 146 did not have a material effect on the
          Company's financial statements.

          In October 2002, FASB issued SFAS No. 147, "Acquisitions of Certain
          Financial Institutions." SFAS No. 147 is effective October 1, 2002.
          The Company believes the adoption of SFAS No. 147 will not have a
          material effect on the Company's financial statements.

          In December 2002, the FASB issued SFAS No. 148, "Accounting for
          Stock-Based Compensation - Transition and Disclosure." SFAS No. 148 is
          an amendment to SFAS No. 123 providing alternative methods of
          transition for a voluntary change to the fair value based method of
          accounting for stock-based employee compensation and also provides
          additional disclosures about the method of accounting for stock-based
          employee compensation. Amendments are effective for financial
          statements for fiscal years ending after December 15, 2002 and for the
          interim periods beginning after December 15, 2002. The Company does
          not have a stock option plan or stock options outstanding and, as
          such, SFAS No. 123 and 148 does not impact the Company's financial
          statements.

          In April 2003, the FASB issued SFAS No. 149, "Amendment of Statement
          133 on Derivative Instruments and Hedging Activities," effective for
          contracts entered into or modified after June 30, 2003. This amendment
          clarifies when a contract meets the characteristics of a derivative,
          clarifies when a derivate contains a financing component and amends
          certain other existing pronouncements. The Company believes the
          adoption of SFAS No. 149 will not have a material effect on the
          Company's financial statements.

          In May 2003, the FASB issued SFAS No. 150, "Accounting for Certain
          Financial Instruments with Characteristics of both Liabilities and
          Equity." SFAS No. 150 is effective for financial instruments entered
          into or modified after May 31, 2003, and otherwise is effective at the
          beginning of the first interim period beginning after June 15, 2003.
          SFAS No. 150 requires the classification as a liability of any
          financial instruments with a mandatory redemption feature, an
          obligation to repurchase equity shares, or a conditional obligation
          based on the issuance of a variable number of its equity shares. The
          Company


                                       7
<PAGE>

Note 1.   Nature of Business and Summary of Significant Accounting Policies
          (Continued):


          ESTIMATES AND ASSUMPTIONS:

          The preparation of the financial statements in conformity with
          accounting principles generally accepted in the United States of
          America requires management to make estimates and assumptions that
          affect the reported amounts of assets and liabilities and disclosure
          of contingent assets and liabilities at the date of the financial
          statements and revenues and expenses during the reporting period.
          Actual results could differ from Company estimates.

          LOSS PER COMMON SHARE:

          Loss per share is computed based on the weighted average number of
          common shares outstanding. Potential issuance's that would reduce loss
          per common share are considered anti-dilutive and are excluded from
          the computation.

          RECLASSIFICATIONS:

          Certain reclassifications have been made to the 2002 financial
          statements to conform to the classifications used in 2003. Such
          reclassifications had no effect on net loss or stockholders' deficit.


Note 2.   Stockholder Rights:

          The convertible preferred stock is convertible into ten common shares
          at a price of $.10 per share for a period of ten years and has no
          voting rights unless converted into common shares.

          The Board of Directors have the power and authority to fix by
          resolution any designation, class, series, voting power, preference,
          right, qualification, limitation, restriction, dividend, time and
          place of redemption and conversion right with respect to any stock of
          the Company.







                                       8
<PAGE>


Note 3.   Income Taxes:

          For income tax purposes, pre-opening costs were deferred and are being
          amortized to expense in future tax returns. The (benefit) for income
          taxes differs from the amount computed by applying the U.S. federal
          income tax rate to loss before income taxes as follows:

                                                               May 31
                                                     --------------------------
                                                         2003          2002
                                                     -----------    -----------
              Expected (benefit) at statutory rate   $  (155,000)   $  (120,000)
              Effect of graduated federal rates           12,500         12,500
              Increase in valuation allowance            142,500        107,500
                                                     -----------    -----------
                                                     $        --    $        --
                                                     ===========    ===========

          The following is a summary of deferred taxes:

                                                               May 31
                                                     --------------------------
                                                         2003          2002
                                                     -----------    -----------
              Deferred tax assets:
                Net operating loss and related
                 party accruals                      $   825,000    $   682,500
                Valuation allowance                     (825,000)      (682,500)
                                                     -----------    -----------
                                                     $        --    $        --
                                                     ===========    ===========

          Tax law provides for limitation on the use of future loss carryovers
          should significant ownership changes occur. The Company has net
          operating loss carry forwards of approximately $2,000,000 that expire
          through the year 2023.


Note 4.   Related Party Transactions:

          The principal stockholder has advanced to the Company or requested
          reimbursement for $1,440,066 and $1,314,920 as of May 31, 2003 and
          2002, respectively. Interest on the advances is at 8% and a total of
          $103,097 and $95,228 was charged to operations for the years ended May
          31, 2003 and 2002, respectively, and is included in the payable to
          stockholder, officer amount at May 31, 2003 and 2002.


Note 5.   Commitments:

          The Company rents office and warehouse space in Las Vegas, Nevada
          under terms of an operating lease which calls for monthly rentals of
          approximately $6,000 plus operating expenses through September 2003.
          Rent expense plus operating expenses under this agreement for the
          years ended May 31, 2003 and 2002 was $77,000 and $94,000,
          respectively.

          Minimum lease payments at May 31, 2003 for the year ending May 31,
          2004 are $24,000.

          The Company is offering 3,000,000 of its shares to its distributors
          under a plan whereby the distributors earn a stock bonus based on
          sales and "bonus points." A distributor who purchases enough product
          for 160 points, sponsors three persons who each purchase enough
          product for 160 points and who in turn sponsor three additional
          persons who each purchase enough product for 160 points will receive
          10 certificates valued at $5.00 each. The number of certificates
          outstanding at May 31, 2003 and 2002 was 43,474 and 21,756,
          respectively. The aggregate value for certificates earned will be
          redeemable for shares at the current market price at the time of
          redemption. The shares of stock are restricted from sale for three
          years from the time of issuance. The liability for the bonus points of
          $217,321 and $108,821 at May 31, 2003 and 2002, respectively, is
          included in accrued compensation.


Note 5.   Commitments (Continued):

          The Company entered into an agreement with a bank whereby a certain
          amount must be deposited into a restricted cash account in exchange
          for credit card processing.

          The Company has entered into an intellectual property license
          agreement with an entity related to the principal stockholder and to a
          separate foundation. The agreement calls for royalty payments to the
          entity


                                       9
<PAGE>

          and foundation that total 8% of "net sales price" subject to a minimum
          royalty fee to the entity related to the principal stockholder and
          other conditions as defined by the agreement. The minimum royalty fee
          for the years ended May 31, 2003 and 2002 were waived by the principal
          stockholder. The amount expensed for the years ended May 31, 2003 and
          2002 was $143,400 and $84,000, respectively, and is included in
          accrued royalties at May 31, 2003 and 2002.


Note 6.   Company's Continued Existence:

          The accompanying financial statements have been prepared in conformity
          with accounting principles generally accepted in the United States of
          America, which contemplate continuation of the Company as a going
          concern. However, the Company has sustained substantial losses and its
          liabilities exceed its assets. The Company intends to generate
          positive cash flows from operations through increased sales utilizing
          the network of distributors in place and obtain necessary capital
          through additional advances from the Company's principal stockholder.























                                       10